OncoSil Medical Limited

ASX (AUD): OncoSil Medical Limited (OSL)

Last Price

1.16

Today's Change

-0.025 (2.10%)

Day's Change

1.15 - 1.19

Trading Volume

82,400

Overview

Market Cap

21 Million

Shares Outstanding

18 Million

Avg Volume

28,863

Avg Price (50 Days)

1.18

Avg Price (200 Days)

2.16

PE Ratio

-0.65

EPS

-1.79

Earnings Announcement

29-Jul-2025

Previous Close

1.19

Open

1.19

Day's Range

1.15 - 1.19

Year Range

0.8 - 6.0

Trading Volume

82,400

Price Change Highlight

1 Day Change

-2.11%

5 Day Change

-3.33%

1 Month Change

19.59%

3 Month Change

-27.50%

6 Month Change

-42.00%

Ytd Change

-58.57%

1 Year Change

-63.75%

3 Year Change

-93.80%

5 Year Change

-96.81%

10 Year Change

-96.61%

Max Change

-97.95%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Devices

Description:

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment